Cargando…

Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.

Detalles Bibliográficos
Autores principales: Das, Santa Kumar, Ranabhat, Kamal, Bhattarai, Suraj, Karki, Khem Bahadur, Gyanwali, Pradip, Paneru, Hem Raj, Nepal, Bipin, Dumre, Shyam Prakash, Acharya, Subhash Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013972/
https://www.ncbi.nlm.nih.gov/pubmed/33821192
http://dx.doi.org/10.1002/ccr3.3964
_version_ 1783673538831450112
author Das, Santa Kumar
Ranabhat, Kamal
Bhattarai, Suraj
Karki, Khem Bahadur
Gyanwali, Pradip
Paneru, Hem Raj
Nepal, Bipin
Dumre, Shyam Prakash
Acharya, Subhash Prasad
author_facet Das, Santa Kumar
Ranabhat, Kamal
Bhattarai, Suraj
Karki, Khem Bahadur
Gyanwali, Pradip
Paneru, Hem Raj
Nepal, Bipin
Dumre, Shyam Prakash
Acharya, Subhash Prasad
author_sort Das, Santa Kumar
collection PubMed
description Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.
format Online
Article
Text
id pubmed-8013972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80139722021-04-01 Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity Das, Santa Kumar Ranabhat, Kamal Bhattarai, Suraj Karki, Khem Bahadur Gyanwali, Pradip Paneru, Hem Raj Nepal, Bipin Dumre, Shyam Prakash Acharya, Subhash Prasad Clin Case Rep Case Reports Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension. John Wiley and Sons Inc. 2021-02-22 /pmc/articles/PMC8013972/ /pubmed/33821192 http://dx.doi.org/10.1002/ccr3.3964 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Das, Santa Kumar
Ranabhat, Kamal
Bhattarai, Suraj
Karki, Khem Bahadur
Gyanwali, Pradip
Paneru, Hem Raj
Nepal, Bipin
Dumre, Shyam Prakash
Acharya, Subhash Prasad
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title_full Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title_fullStr Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title_full_unstemmed Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title_short Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
title_sort combination of convalescent plasma therapy and repurposed drugs to treat severe covid‐19 patient with multimorbidity
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013972/
https://www.ncbi.nlm.nih.gov/pubmed/33821192
http://dx.doi.org/10.1002/ccr3.3964
work_keys_str_mv AT dassantakumar combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT ranabhatkamal combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT bhattaraisuraj combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT karkikhembahadur combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT gyanwalipradip combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT paneruhemraj combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT nepalbipin combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT dumreshyamprakash combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity
AT acharyasubhashprasad combinationofconvalescentplasmatherapyandrepurposeddrugstotreatseverecovid19patientwithmultimorbidity